Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Tongue discomfort, Tongue pruritus, Viral test
Clinical narrative: nervous; whole body itching; tongue was itchy and burning; tongue was itchy and burning; cough; headache; fever; lower back pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 20 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 07Oct2021 11:00 (Lot number: 301258A) at the age of 20 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Small adenoma" (unspecified if ongoing), notes: Illness/AE: none.  Small adenoma. , Onset Date: 3 years ago.; "diagnosed allergies" (unspecified if ongoing); "compromised immune status" (unspecified if ongoing); "respiratory illness" (unspecified if ongoing); "genetic/chromosomal abnormalities" (unspecified if ongoing); "endocrine abnormalities" (unspecified if ongoing), notes: including diabetes; "obesity" (unspecified if ongoing). There were no concomitant medications. The following information was reported: TONGUE DISCOMFORT (non-serious), TONGUE PRURITUS (non-serious) all with onset 11Oct2021, outcome "recovering" and all described as "tongue was itchy and burning"; PYREXIA (non-serious) with onset 07Oct2021, outcome "recovering", described as "fever"; COUGH (non-serious) with onset 10Oct2021, outcome "unknown", described as "cough"; PRURITUS (non-serious) with onset 13Oct2021, outcome "not recovered", described as "whole body itching"; BACK PAIN (non-serious) with onset 07Oct2021, outcome "recovering", described as "lower back pain"; HEADACHE (non-serious) with onset 08Oct2021, outcome "recovering", described as "headache"; NERVOUSNESS (non-serious), outcome "unknown", described as "nervous". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, back pain, headache.  Additional Context: Received call from consumer regarding the Pfizer COVID vaccine.  She received first dose 8 days ago and after that she has a fever.  She checked for COVID and it was negative. She also checked for other viruses and that was negative. She was also coughing a lot and has whole body itching.  She did not have an address, phone, or email for her primary care provider. When asked to provide outcome of the fever, she stated that her fever was getting higher and she got pills to reduce it, and it lowered it.  When asked to provide outcome for cough, she stated that the cough also was sometimes better, but sometimes worse. If she coughs once it may continue for 15 minutes. It does not stop. She gets nervous sometimes. She took Tylenol for the lower back pain and maybe Ibuprofen for headache. No further details provided. She checked for COVID twice and it was negative.  She also did a RPP test and it was negative. She has no viruses. The patient was not received any other vaccinations within four weeks prior to the first administration date of the suspect vaccine within 4 weeks.  No follow-up attempts are possible. No further information is expected.